Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
UTC Therapeutics Inc.
Chongqing Precision Biotech Co., Ltd
SpeciCare
Proteus Digital Health, Inc.
Leaf Vertical Inc.
LifeBond Ltd.
SPGO Research Mannheim GmbH
Mast Therapeutics, Inc.